Key result
Dilated cardiomyopathy incidence reaches ~6.0 per 100,000 person-years, more than double hypertrophic cardiomyopathy.
Why the study?
Accurate epidemiologic data on the incidence and prevalence of idiopathic dilated and hypertrophic cardiomyopathy in a defined population were needed to inform healthcare resource planning.
Observational (n=64)
No
This population-based study provides historical incidence and prevalence estimates for idiopathic dilated and hypertrophic cardiomyopathy, highlighting an increase in diagnosed cases over a 10-year period.
Using the records linkage system of the Mayo Clinic and of the Rochester Epidemiology Project, which accesses diagnostic data on the entire population of Olmsted County, Minnesota, we identified 45 new cases of idiopathic dilated cardiomyopathy (DCM) and 19 new cases of hypertrophic cardiomyopathy (HCM) among county residents for the years 1975-1984. Overall age- and sex-adjusted incidence rates were 6.0/100,000 and 2.5/100,000 person-years, respectively. The incidence of DCM doubled from 3.9/100,000 in the first 5 years to 7.9/100,000 person-years in the last 5 years of study. The corresponding change for HCM was from 1.4 to 3.6/100,000 person-years. Age- and sex-adjusted prevalence rates as of January 1, 1985, for DCM and HCM were 36.5/100,000 and 19.7/100,000 population, respectively. The prevalence of DCM in persons less than 55 years old was 17.9/100,000, over a third of whom were New York Heart Association functional Class III or IV at diagnosis. These estimates may be of value in determining the potential use of health care resources, particularly cardiac transplantation.
No takes yet. Share an insight, caveat, or question.
Codd et al. (1989) conducted an observational in Idiopathic dilated and hypertrophic cardiomyopathy (n=64). Olmsted County residency was evaluated on Incidence and prevalence of DCM and HCM. The overall age- and sex-adjusted incidence rates in Olmsted County from 1975-1984 were 6.0/100,000 person-years for dilated cardiomyopathy and 2.5/100,000 for hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: